Jung, Jeesun

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III

Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry

Substance Abuse Treatment and OutcomesMental Health Treatment and Access

Cited by 2,556

Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Grant, B. F., Chou, S. P., Saha, T. D., Pickering, R. P., Kerridge, B. T., Ruan, W. J., Huang, B., Jung, J., Zhang, H., Fan, A., et al. (2017) · JAMA Psychiatry

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 1,362

Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.

Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., et al. (2015) · JAMA Psychiatry

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 1,086

Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions–III

Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., Zhang, H., Smith, S. M., Pickering, R. P., Huang, B., et al. (2016) · JAMA Psychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 877

Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions–III

Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016) · American Journal of Psychiatry

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 579

The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Reliability of substance use and psychiatric disorder modules in a general population sample

Grant, B. F., Goldstein, R. B., Smith, S. M., Jung, J., Zhang, H., Chou, S. P., Pickering, R. P., Ruan, W. J., Huang, B., Saha, T. D., et al. (2015) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 346

Identification of Pathways for Bipolar Disorder: A Meta-analysis

Nurnberger, J. I., Koller, D. L., Jung, J., Edenberg, H. J., Foroud, T., Guella, I., Vawter, M. P., & Kelsoe, J. R. (2014) · JAMA Psychiatry

Bipolar Disorder and TreatmentGenetic Associations and Epidemiology

Cited by 234

Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States

Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2016) · The Journal of Clinical Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 222

Intensified Effect of Adiposity on Blood Pressure in Overweight and Obese Children

Tu, W., Eckert, G. J., DiMeglio, L. A., Yu, Z., Jung, J., & Pratt, J. H. (2011) · Hypertension

Blood Pressure and Hypertension StudiesObesity, Physical Activity, Diet

Cited by 141

Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function

Rosoff, D. B., Bell, A. S., Jung, J., Wagner, J., Mavromatis, L. A., & Lohoff, F. W. (2022) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 126

Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population

Hasin, D. S., Shmulewitz, D., Stohl, M., Greenstein, E., Aivadyan, C., Morita, K., Saha, T., Aharonovich, E., Jung, J., Zhang, H., et al. (2015) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 107

The Epidemiology of DSM-5 Nicotine Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III

Chou, S. P., Goldstein, R. B., Smith, S. M., Huang, B., Ruan, W. J., Zhang, H., Jung, J., Saha, T. D., Pickering, R. P., & Grant, B. F. (2016) · The Journal of Clinical Psychiatry

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 106

Prevalence and Correlates of Past-Year Recovery From DSM-5 Alcohol Use Disorder: Results from National Epidemiologic Survey on Alcohol and Related Conditions-III

Fan, A. Z., Chou, S. P., Zhang, H., Jung, J., & Grant, B. F. (2019) · Alcoholism: Clinical and Experimental Research

Substance Abuse Treatment and OutcomesGambling Behavior and Treatments

Cited by 104

PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury

Wagner, J., Park, L. M., Mukhopadhyay, P., Matyas, C., Trojnar, E., Damadzic, R., Jung, J., Bell, A. S., Mavromatis, L. A., Hamandi, A. M., et al. (2024) · Brain, Behavior, and Immunity

Neuroinflammation and Neurodegeneration MechanismsAlcohol Consumption and Health Effects

Cited by 26

Multiomic Mendelian Randomization Study Investigating the Impact of PCSK9 and HMGCR Inhibition on Type 2 Diabetes Across Five Populations

Rosoff, D. B., Wagner, J., Jung, J., Pacher, P., Christodoulides, C., Davey Smith, G., Ray, D., & Lohoff, F. W. (2025) · Diabetes

Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health

Cited by 10